JP2019534046A - ガンマ−ポリグルタミン酸および亜鉛組成物 - Google Patents

ガンマ−ポリグルタミン酸および亜鉛組成物 Download PDF

Info

Publication number
JP2019534046A
JP2019534046A JP2019545868A JP2019545868A JP2019534046A JP 2019534046 A JP2019534046 A JP 2019534046A JP 2019545868 A JP2019545868 A JP 2019545868A JP 2019545868 A JP2019545868 A JP 2019545868A JP 2019534046 A JP2019534046 A JP 2019534046A
Authority
JP
Japan
Prior art keywords
zinc
dosage form
kda
composition
solid dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019545868A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019534046A5 (enExample
Inventor
チュン，ジニョク・フレッド
Original Assignee
ジロニックス・アイピー・ホールディングス・ピーティーイー．リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジロニックス・アイピー・ホールディングス・ピーティーイー．リミテッド filed Critical ジロニックス・アイピー・ホールディングス・ピーティーイー．リミテッド
Publication of JP2019534046A publication Critical patent/JP2019534046A/ja
Publication of JP2019534046A5 publication Critical patent/JP2019534046A5/ja
Priority to JP2022144662A priority Critical patent/JP2023016043A/ja
Priority to JP2025117126A priority patent/JP2025148479A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2045—Polyamides; Polyaminoacids, e.g. polylysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2019545868A 2016-11-01 2017-10-31 ガンマ−ポリグルタミン酸および亜鉛組成物 Pending JP2019534046A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022144662A JP2023016043A (ja) 2016-11-01 2022-09-12 ガンマ－ポリグルタミン酸および亜鉛組成物
JP2025117126A JP2025148479A (ja) 2016-11-01 2025-07-11 ガンマ－ポリグルタミン酸および亜鉛組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201609137P 2016-11-01
SG10201609137PA SG10201609137PA (en) 2016-11-01 2016-11-01 Gamma-polyglutamic acid and zinc compositions
PCT/SG2017/050544 WO2018084805A1 (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022144662A Division JP2023016043A (ja) 2016-11-01 2022-09-12 ガンマ－ポリグルタミン酸および亜鉛組成物

Publications (2)

Publication Number Publication Date
JP2019534046A true JP2019534046A (ja) 2019-11-28
JP2019534046A5 JP2019534046A5 (enExample) 2020-12-10

Family

ID=60582642

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019545868A Pending JP2019534046A (ja) 2016-11-01 2017-10-31 ガンマ−ポリグルタミン酸および亜鉛組成物
JP2022144662A Pending JP2023016043A (ja) 2016-11-01 2022-09-12 ガンマ－ポリグルタミン酸および亜鉛組成物
JP2025117126A Pending JP2025148479A (ja) 2016-11-01 2025-07-11 ガンマ－ポリグルタミン酸および亜鉛組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022144662A Pending JP2023016043A (ja) 2016-11-01 2022-09-12 ガンマ－ポリグルタミン酸および亜鉛組成物
JP2025117126A Pending JP2025148479A (ja) 2016-11-01 2025-07-11 ガンマ－ポリグルタミン酸および亜鉛組成物

Country Status (12)

Country Link
US (2) US20190247428A1 (enExample)
EP (1) EP3534915B1 (enExample)
JP (3) JP2019534046A (enExample)
KR (1) KR20190122203A (enExample)
CN (1) CN108014130A (enExample)
AU (2) AU2017354786B2 (enExample)
CA (1) CA3042234A1 (enExample)
DK (1) DK3534915T3 (enExample)
ES (1) ES2969208T3 (enExample)
MX (2) MX2019005103A (enExample)
SG (2) SG10201609137PA (enExample)
WO (1) WO2018084805A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102094182B1 (ko) * 2018-06-28 2020-03-30 주식회사 알랙스탠드 아연 함유 수용성 폴리글루타믹산 복합체 조성물
WO2023168365A1 (en) 2022-03-02 2023-09-07 Jds Therapeutics, Llc Polyglutamic acid compositions and methods of using
CN117224690B (zh) * 2023-11-10 2024-01-30 江苏海王健康生物科技有限公司 一种作为助剂的γ-聚谷氨酸混合物、组合物、制备方法

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0330648A (ja) * 1989-06-28 1991-02-08 Ajinomoto Co Inc 易吸収性ミネラル含有飲食物
JPH05316999A (ja) * 1992-03-24 1993-12-03 Ajinomoto Co Inc 易吸収性ミネラル含有組成物及びそれを含有する飲食品
JPH11313618A (ja) * 1998-05-06 1999-11-16 Yoshio Inoue 胃にやさしい家畜用ミネラル（亜鉛）製剤及びその製造法
JP2001204441A (ja) * 1992-03-24 2001-07-31 Ajinomoto Co Inc 易吸収性ミネラル含有組成物及びそれを含有する飲食品
JP2006045216A (ja) * 2004-07-08 2006-02-16 Taisho Pharmaceut Co Ltd 亜鉛含有経口投与用組成物
WO2007043606A1 (ja) * 2005-10-12 2007-04-19 Genolac Bl Corporation アニオン性ポリアミノ酸／金属複合体からなる抗糖尿病薬剤
CN101716180A (zh) * 2009-11-06 2010-06-02 广西强寿药业集团有限公司 一种组合补充锌、钙药物及其制备方法
JP2012523413A (ja) * 2009-04-10 2012-10-04 サイプレス ファーマシューティカルズ， インコーポレイテッド ホスフェート結合性マグネシウム塩およびその使用
JP2012527458A (ja) * 2009-05-18 2012-11-08 ミレニアム ファーマシューティカルズ， インコーポレイテッド 固体薬学的組成物およびそれらの生産のためのプロセス
JP2013522185A (ja) * 2010-03-10 2013-06-13 ルピン・リミテッド リファキシミン使用準備済懸濁液
WO2014133196A1 (en) * 2013-03-01 2014-09-04 Otsuka Pharmaceutical Co., Ltd. Suspension for oral administration comprising amorphous tolvaptan
JP2014526503A (ja) * 2011-09-13 2014-10-06 ファーマサイクリックス，インク． ベンダムスチンと組み合わせたヒストンデアセチラーゼ阻害剤の製剤とその使用
JP2016501862A (ja) * 2012-11-21 2016-01-21 ケイビーエス リサーチ、 エルエルシー ハーブサプリメントおよびその使用の方法
EP3006045A1 (en) * 2014-10-07 2016-04-13 Cyprumed GmbH Pharmaceutical formulations for the oral delivery of peptide or protein drugs
WO2016057744A1 (en) * 2014-10-08 2016-04-14 Synthetic Biologics, Inc. Beta-lactamase formulations and uses thereof
JP2016069303A (ja) * 2014-09-29 2016-05-09 タカラバイオ株式会社 フコイダンを有効成分とする脱毛抑制用組成物
WO2016088816A1 (ja) * 2014-12-03 2016-06-09 ノーベルファーマ株式会社 酢酸亜鉛水和物錠及びその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447732A (en) * 1992-11-25 1995-09-05 Ajinomoto Co., Inc. High-absorption mineral-containing composition and foods
IT1275923B1 (it) * 1995-03-16 1997-10-24 Valpharma Sa Formulazioni gastroresistenti contenenti zinco
WO2004080210A1 (en) * 2003-03-14 2004-09-23 Boehringer Ingelheim Danmark A/S Compositions of dietary metals for support of the physiological intestinal development and prevention of diarrhoea
JP4457641B2 (ja) * 2003-11-10 2010-04-28 味の素株式会社 ゼラチンカプセル
CN101692851B (zh) * 2009-10-20 2014-01-08 华中农业大学 γ-聚谷氨酸或其盐类作为添加剂在乳制品中的应用
CN103690521B (zh) * 2013-11-29 2016-07-06 湖北福人金身药业有限公司 一种葡萄糖酸钙锌口服溶液

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0330648A (ja) * 1989-06-28 1991-02-08 Ajinomoto Co Inc 易吸収性ミネラル含有飲食物
JPH05316999A (ja) * 1992-03-24 1993-12-03 Ajinomoto Co Inc 易吸収性ミネラル含有組成物及びそれを含有する飲食品
JP2001204441A (ja) * 1992-03-24 2001-07-31 Ajinomoto Co Inc 易吸収性ミネラル含有組成物及びそれを含有する飲食品
JPH11313618A (ja) * 1998-05-06 1999-11-16 Yoshio Inoue 胃にやさしい家畜用ミネラル（亜鉛）製剤及びその製造法
JP2006045216A (ja) * 2004-07-08 2006-02-16 Taisho Pharmaceut Co Ltd 亜鉛含有経口投与用組成物
WO2007043606A1 (ja) * 2005-10-12 2007-04-19 Genolac Bl Corporation アニオン性ポリアミノ酸／金属複合体からなる抗糖尿病薬剤
JP2012523413A (ja) * 2009-04-10 2012-10-04 サイプレス ファーマシューティカルズ， インコーポレイテッド ホスフェート結合性マグネシウム塩およびその使用
JP2012527458A (ja) * 2009-05-18 2012-11-08 ミレニアム ファーマシューティカルズ， インコーポレイテッド 固体薬学的組成物およびそれらの生産のためのプロセス
CN101716180A (zh) * 2009-11-06 2010-06-02 广西强寿药业集团有限公司 一种组合补充锌、钙药物及其制备方法
JP2013522185A (ja) * 2010-03-10 2013-06-13 ルピン・リミテッド リファキシミン使用準備済懸濁液
JP2014526503A (ja) * 2011-09-13 2014-10-06 ファーマサイクリックス，インク． ベンダムスチンと組み合わせたヒストンデアセチラーゼ阻害剤の製剤とその使用
JP2016501862A (ja) * 2012-11-21 2016-01-21 ケイビーエス リサーチ、 エルエルシー ハーブサプリメントおよびその使用の方法
WO2014133196A1 (en) * 2013-03-01 2014-09-04 Otsuka Pharmaceutical Co., Ltd. Suspension for oral administration comprising amorphous tolvaptan
JP2016069303A (ja) * 2014-09-29 2016-05-09 タカラバイオ株式会社 フコイダンを有効成分とする脱毛抑制用組成物
EP3006045A1 (en) * 2014-10-07 2016-04-13 Cyprumed GmbH Pharmaceutical formulations for the oral delivery of peptide or protein drugs
WO2016057744A1 (en) * 2014-10-08 2016-04-14 Synthetic Biologics, Inc. Beta-lactamase formulations and uses thereof
WO2016088816A1 (ja) * 2014-12-03 2016-06-09 ノーベルファーマ株式会社 酢酸亜鉛水和物錠及びその製造方法

Also Published As

Publication number Publication date
CA3042234A1 (en) 2018-05-11
MX2022013541A (es) 2022-11-16
ES2969208T3 (es) 2024-05-17
JP2023016043A (ja) 2023-02-01
CN108014130A (zh) 2018-05-11
MX2019005103A (es) 2019-10-30
AU2023203216B2 (en) 2025-08-07
US20190247428A1 (en) 2019-08-15
SG10201609137PA (en) 2018-06-28
US20250041333A1 (en) 2025-02-06
AU2017354786A1 (en) 2019-05-16
SG11201903732TA (en) 2019-05-30
KR20190122203A (ko) 2019-10-29
AU2023203216A1 (en) 2023-06-22
EP3534915B1 (en) 2023-12-20
DK3534915T3 (da) 2024-01-22
JP2025148479A (ja) 2025-10-07
AU2017354786B2 (en) 2023-02-23
WO2018084805A1 (en) 2018-05-11
EP3534915A1 (en) 2019-09-11

Similar Documents

Publication Publication Date Title
JP2025148479A (ja) ガンマ－ポリグルタミン酸および亜鉛組成物
JP7466822B2 (ja) 亜鉛－γ－ＰＧＡ組成物およびがんを処置するための方法
TW200831115A (en) Manufacture process
TW200908892A (en) Nutritional dosage unit
JP2002543107A (ja) 葉酸補給物
US6447807B1 (en) Potassium (-)-hydroxycitric acid methods for pharmaceutical preparations for stable and controlled delivery
CN101257804A (zh) 用于微生物的肠应用的组合物
EP0620730B1 (en) Prolamine coatings for taste-masking orally-administrable medicaments
ITBO20120226A1 (it) Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso.
WO2011059075A1 (ja) グルタミン酸およびアルギニンの高含有製剤
JP2511577B2 (ja) アルギン酸プロピレングリコ―ルエステルからなる徐放性製剤
US20040101555A1 (en) Method for stable and controlled delivery of (—)-hydroxycitric acid
JP7352541B2 (ja) がんを処置するためのアルファ－ポリグルタミン酸－亜鉛を含む組成物
JP2002193831A (ja) ヘム鉄含有経口用組成物
KR20220084098A (ko) 분산성 연장 방출형 조성물 및 그를 제조하기 위한 공정
KR100910000B1 (ko) 리파아제 저해제 함유 약학 조성물
CN106821998A (zh) 制备维生素ad微丸的方法及其复方氨基酸胶囊组合物
TW202304454A (zh) 控制釋放口服製劑及其製備方法
JP2003073262A (ja) 固型製剤用包摂コーティング剤、固型製剤、その製造方法、及び食品類

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201029

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201029

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210817

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210820

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220217

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220511

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220912

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220912

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20220922

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20221116

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20221117

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230203

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20230207

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20240304

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241016

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250116